BioXcel Therapeutics (BTAI) Total Debt (2017 - 2026)
BioXcel Therapeutics (BTAI) total debt from Mar 29, 2017 to Mar 31, 2026. The current BioXcel Therapeutics (BTAI) total debt is $140M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Debt
Total Debt
BioXcel Therapeutics (BTAI) Total Debt CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +2.37% |
| 3 Years TTM | +6.11% |
| 5 Years TTM | +54.69% |
| All Time TTM | +97.65% |
Annual Total Debt change of BioXcel Therapeutics (BTAI)
| Year | Total Debt | Change |
|---|---|---|
| 2025 | $140M | +6.80% |
| 2024 | $131M | +0.94% |
| 2023 | $130M | +0.88% |
| 2022 | $129M | +626.39% |
| 2021 | $18M | +34.21% |
| 2020 | $13M | +39.37% |
| 2019 | $9.50M | +103.86% |
| 2018 | $4.66M | +99.15% |
| 2017 | $2.34M | N/A |
| 2017 | $0 | N/A |
Comparison BioXcel Therapeutics (BTAI) total debt with competitors
BioXcel Therapeutics (BTAI) total debt is $139.57M.